Paclitaxel-Loaded, Pegylated Carboxylic Graphene Oxide with High Colloidal Stability, Sustained, pH-Responsive Release and Strong Anticancer Effects on Lung Cancer A549 Cell Line

<b>Background</b>: Graphene Oxide (GO) has shown great potential in biomedical applications for cancer therapeutics. The biosafety and stability issues of GO in biological media have been addressed by functionalization with polyethylene glycol (PEG). <b>Methods</b>: In this w...

Full description

Saved in:
Bibliographic Details
Main Authors: Athina Angelopoulou, Myria Papachristodoulou, Efstathia Voulgari, Andreas Mouikis, Panagiota Zygouri, Dimitrios P. Gournis, Konstantinos Avgoustakis
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Pharmaceutics
Subjects:
Online Access:https://www.mdpi.com/1999-4923/16/11/1452
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850226640591781888
author Athina Angelopoulou
Myria Papachristodoulou
Efstathia Voulgari
Andreas Mouikis
Panagiota Zygouri
Dimitrios P. Gournis
Konstantinos Avgoustakis
author_facet Athina Angelopoulou
Myria Papachristodoulou
Efstathia Voulgari
Andreas Mouikis
Panagiota Zygouri
Dimitrios P. Gournis
Konstantinos Avgoustakis
author_sort Athina Angelopoulou
collection DOAJ
description <b>Background</b>: Graphene Oxide (GO) has shown great potential in biomedical applications for cancer therapeutics. The biosafety and stability issues of GO in biological media have been addressed by functionalization with polyethylene glycol (PEG). <b>Methods</b>: In this work, carboxylated, nanosized GO (nCGO) was evaluated as a potential carrier of paclitaxel (PCT). The effect of PEG characteristics on particle size and surface charge, colloidal stability, drug, and release, and the hemolytic potential of nCGO, was investigated. Optimum PEG-nCGO/PCT formulations based on the above properties were evaluated for their anticancer activity (cytotoxicity and apoptosis induction) in the A549 lung cancer cell line. <b>Results</b>: An increase in the length of linear PEG chains and the use of branched (4-arm) instead of linear PEG resulted in a decrease in hydrodynamic diameter and an increase in ζ potential of the pegylated nCGO particles. Pegylated nCGO exhibited high colloidal stability in phosphate-buffered saline and in cell culture media and low hemolytic effect, even at a relatively high concentration of 1 mg/mL. The molecular weight of PEG and branching adversely affected PCT loading. An increased rate of PCT release at an acidic pH of 6.0 compared to the physiological pH of 7.4 was observed with all types of pegylated nCGO/PCT. Pegylated nCGO exhibited lower cytotoxicity and apoptotic activity than non-pegylated nCGO. Cellular uptake of pegylated nCGO increased with incubation time with cells leading to increased cytotoxicity of PEG-nCGO/PCT with incubation time, which became higher than that of free PCT at 24 and 48 h of incubation. <b>Conclusions</b>: The increased biocompatibility of the pegylated nCGO and the enhanced anticancer activity of PEG-nCGO/PCT compared to free PCT are desirable properties with regard to the potential clinical application of PEG-nCGO/PCT as an anticancer nanomedicine.
format Article
id doaj-art-b60e0dbdf20a4350af1a16ee0959988b
institution OA Journals
issn 1999-4923
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Pharmaceutics
spelling doaj-art-b60e0dbdf20a4350af1a16ee0959988b2025-08-20T02:05:01ZengMDPI AGPharmaceutics1999-49232024-11-011611145210.3390/pharmaceutics16111452Paclitaxel-Loaded, Pegylated Carboxylic Graphene Oxide with High Colloidal Stability, Sustained, pH-Responsive Release and Strong Anticancer Effects on Lung Cancer A549 Cell LineAthina Angelopoulou0Myria Papachristodoulou1Efstathia Voulgari2Andreas Mouikis3Panagiota Zygouri4Dimitrios P. Gournis5Konstantinos Avgoustakis6Department of Pharmacy, Medical School, University of Patras, 26504 Patras, GreeceDepartment of Pharmacy, Medical School, University of Patras, 26504 Patras, GreeceDepartment of Pharmacy, Medical School, University of Patras, 26504 Patras, GreeceDepartment of Pharmacy, Medical School, University of Patras, 26504 Patras, GreeceDepartment of Materials Science and Engineering, University of Ioannina, 45110 Ioannina, GreeceSchool of Chemical and Environmental Engineering, Technical University of Crete, 73100 Chania, GreeceDepartment of Pharmacy, Medical School, University of Patras, 26504 Patras, Greece<b>Background</b>: Graphene Oxide (GO) has shown great potential in biomedical applications for cancer therapeutics. The biosafety and stability issues of GO in biological media have been addressed by functionalization with polyethylene glycol (PEG). <b>Methods</b>: In this work, carboxylated, nanosized GO (nCGO) was evaluated as a potential carrier of paclitaxel (PCT). The effect of PEG characteristics on particle size and surface charge, colloidal stability, drug, and release, and the hemolytic potential of nCGO, was investigated. Optimum PEG-nCGO/PCT formulations based on the above properties were evaluated for their anticancer activity (cytotoxicity and apoptosis induction) in the A549 lung cancer cell line. <b>Results</b>: An increase in the length of linear PEG chains and the use of branched (4-arm) instead of linear PEG resulted in a decrease in hydrodynamic diameter and an increase in ζ potential of the pegylated nCGO particles. Pegylated nCGO exhibited high colloidal stability in phosphate-buffered saline and in cell culture media and low hemolytic effect, even at a relatively high concentration of 1 mg/mL. The molecular weight of PEG and branching adversely affected PCT loading. An increased rate of PCT release at an acidic pH of 6.0 compared to the physiological pH of 7.4 was observed with all types of pegylated nCGO/PCT. Pegylated nCGO exhibited lower cytotoxicity and apoptotic activity than non-pegylated nCGO. Cellular uptake of pegylated nCGO increased with incubation time with cells leading to increased cytotoxicity of PEG-nCGO/PCT with incubation time, which became higher than that of free PCT at 24 and 48 h of incubation. <b>Conclusions</b>: The increased biocompatibility of the pegylated nCGO and the enhanced anticancer activity of PEG-nCGO/PCT compared to free PCT are desirable properties with regard to the potential clinical application of PEG-nCGO/PCT as an anticancer nanomedicine.https://www.mdpi.com/1999-4923/16/11/1452graphene oxidepaclitaxelpegylationcolloidal stabilitycytotoxicityprogrammed cell death
spellingShingle Athina Angelopoulou
Myria Papachristodoulou
Efstathia Voulgari
Andreas Mouikis
Panagiota Zygouri
Dimitrios P. Gournis
Konstantinos Avgoustakis
Paclitaxel-Loaded, Pegylated Carboxylic Graphene Oxide with High Colloidal Stability, Sustained, pH-Responsive Release and Strong Anticancer Effects on Lung Cancer A549 Cell Line
Pharmaceutics
graphene oxide
paclitaxel
pegylation
colloidal stability
cytotoxicity
programmed cell death
title Paclitaxel-Loaded, Pegylated Carboxylic Graphene Oxide with High Colloidal Stability, Sustained, pH-Responsive Release and Strong Anticancer Effects on Lung Cancer A549 Cell Line
title_full Paclitaxel-Loaded, Pegylated Carboxylic Graphene Oxide with High Colloidal Stability, Sustained, pH-Responsive Release and Strong Anticancer Effects on Lung Cancer A549 Cell Line
title_fullStr Paclitaxel-Loaded, Pegylated Carboxylic Graphene Oxide with High Colloidal Stability, Sustained, pH-Responsive Release and Strong Anticancer Effects on Lung Cancer A549 Cell Line
title_full_unstemmed Paclitaxel-Loaded, Pegylated Carboxylic Graphene Oxide with High Colloidal Stability, Sustained, pH-Responsive Release and Strong Anticancer Effects on Lung Cancer A549 Cell Line
title_short Paclitaxel-Loaded, Pegylated Carboxylic Graphene Oxide with High Colloidal Stability, Sustained, pH-Responsive Release and Strong Anticancer Effects on Lung Cancer A549 Cell Line
title_sort paclitaxel loaded pegylated carboxylic graphene oxide with high colloidal stability sustained ph responsive release and strong anticancer effects on lung cancer a549 cell line
topic graphene oxide
paclitaxel
pegylation
colloidal stability
cytotoxicity
programmed cell death
url https://www.mdpi.com/1999-4923/16/11/1452
work_keys_str_mv AT athinaangelopoulou paclitaxelloadedpegylatedcarboxylicgrapheneoxidewithhighcolloidalstabilitysustainedphresponsivereleaseandstronganticancereffectsonlungcancera549cellline
AT myriapapachristodoulou paclitaxelloadedpegylatedcarboxylicgrapheneoxidewithhighcolloidalstabilitysustainedphresponsivereleaseandstronganticancereffectsonlungcancera549cellline
AT efstathiavoulgari paclitaxelloadedpegylatedcarboxylicgrapheneoxidewithhighcolloidalstabilitysustainedphresponsivereleaseandstronganticancereffectsonlungcancera549cellline
AT andreasmouikis paclitaxelloadedpegylatedcarboxylicgrapheneoxidewithhighcolloidalstabilitysustainedphresponsivereleaseandstronganticancereffectsonlungcancera549cellline
AT panagiotazygouri paclitaxelloadedpegylatedcarboxylicgrapheneoxidewithhighcolloidalstabilitysustainedphresponsivereleaseandstronganticancereffectsonlungcancera549cellline
AT dimitriospgournis paclitaxelloadedpegylatedcarboxylicgrapheneoxidewithhighcolloidalstabilitysustainedphresponsivereleaseandstronganticancereffectsonlungcancera549cellline
AT konstantinosavgoustakis paclitaxelloadedpegylatedcarboxylicgrapheneoxidewithhighcolloidalstabilitysustainedphresponsivereleaseandstronganticancereffectsonlungcancera549cellline